Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Deposul
2. Sulphadimethoxine
1. Sulphadimethoxine
2. 122-11-2
3. Sulfadimethoxin
4. Sulfadimethoxydiazine
5. Sulfadimetoxin
6. Albon
7. 4-amino-n-(2,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
8. 4-amino-n-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
9. Dimetazina
10. Sulfadimetoxina
11. Agribon
12. Deposul
13. Madribon
14. Sulfadimethoxinum
15. Arnosulfan
16. Bactrovet
17. Diasulfa
18. Diasulfyl
19. Dimethoxysulfadiazine
20. Madrigid
21. Madriqid
22. Madroxin
23. Madroxine
24. Maxulvet
25. Memcozine
26. Metoxidon
27. Neostrepal
28. Persulfen
29. Roscosulf
30. Scandisil
31. Sulfastop
32. Sulfoplan
33. Theracanzan
34. Dinosol
35. Dorisul
36. Omnibon
37. Radonin
38. Redifal
39. Sudine
40. Sulxin
41. Symbio
42. Abcid
43. Fuxal
44. Sulfadimetossina
45. 2,6-dimethoxy-4-sulfanilamidopyrimidine
46. Benzenesulfonamide, 4-amino-n-(2,6-dimethoxy-4-pyrimidinyl)-
47. 2,4-dimethoxy-6-sulfanilamido-1,3-diazine
48. 6-sulfanilamido-2,4-dimethoxypyrimidine
49. Agribon (tn)
50. Abcid (tn)
51. 2,6-dimethoxy-4-(p-aminobenzenesulfonamido)pyrimidine
52. Nsc 683544
53. Chebi:32161
54. 4-amino-n-(2,6-dimethoxypyrimidin-4-yl)benzene-1-sulfonamide
55. N1-(2,6-dimethoxy-4-pyrimidinyl)sulfanilamide
56. 30cpc5ldex
57. Nsc-683544
58. Nsc-757860
59. N(sup 1)-(2,6-dimethoxy-4-pyrimidinyl)sulfanilamide
60. Mls000069720
61. N(1)-(2,6-dimethoxy-4-pyrimidinyl)sulfanilamide
62. Nsc683544
63. Sulfanilamide, N(sup 1)-(2,6-dimethoxy-4-pyrimidinyl)-
64. Ncgc00016375-01
65. Cas-122-11-2
66. Smr000017367
67. Solfadimetossina
68. Dsstox_cid_3607
69. Dsstox_rid_77105
70. Dsstox_gsid_23607
71. Sulfadimetoxine
72. Neostreptal
73. Sulfadimoxine
74. Suldixine
75. Sulfabon
76. Sulfadimethoxine [jan]
77. Solfadimetossina [dcit]
78. Sulfadimetossina [italian]
79. Sulfadimethoxinum [inn-latin]
80. Sulfadimetoxina [inn-spanish]
81. Sulfamed-g
82. Sr-01000000227
83. Einecs 204-523-7
84. Unii-30cpc5ldex
85. Brn 0306856
86. Ultrasulfon
87. Lasibon
88. Mecozine
89. Sumbio
90. Sdmo
91. Ccris 9326
92. Prestwick_979
93. Mfcd00057345
94. Rofenaid (salt/mix)
95. 4-amino-n-(2,6-dimethoxy-4-pyrimidinyl)benzolsulfonamid
96. Spectrum_001408
97. Sulfadimethoxine [usp:inn:ban:jan:nf]
98. Opera_id_1856
99. Prestwick0_000728
100. Prestwick1_000728
101. Prestwick2_000728
102. Prestwick3_000728
103. Spectrum2_001419
104. Spectrum3_001454
105. Spectrum4_000442
106. Spectrum5_001221
107. Cbkinase1_000256
108. Cbkinase1_012656
109. Epitope Id:122237
110. Cambridge Id 5251398
111. Oprea1_486812
112. Oprea1_495206
113. Schembl93845
114. Sulfadimethoxine (jan/usp)
115. Bspbio_000656
116. Bspbio_002947
117. Kbiogr_000824
118. Kbioss_001888
119. Sulfadimethoxine [mi]
120. 5-25-13-00290 (beilstein Handbook Reference)
121. Mls000103402
122. Mls000104965
123. Mls001148602
124. Chembl62193
125. Divk1c_000088
126. Spectrum1501144
127. Sulfadimethoxine [inn]
128. Spbio_001498
129. Spbio_002595
130. Bpbio1_000722
131. Component Of Prazil (salt/mix)
132. Component Of Primor (salt/mix)
133. Dtxsid1023607
134. Sulfadimethoxine [mart.]
135. Hms500e10
136. Kbio1_000088
137. Kbio2_001888
138. Kbio2_004456
139. Kbio2_007024
140. Kbio3_002447
141. 4-sulfa-2,6-dimethoxypyrimidine
142. Sulfadimethoxine [usp-rs]
143. Sulfadimethoxine [who-dd]
144. Component Of Maxutrim (salt/mix)
145. Component Of Rofenaid (salt/mix)
146. Ninds_000088
147. [(4-aminophenyl)sulfonyl](2,6-dimethoxypyrimidin-4-yl)amine
148. Hms1570a18
149. Hms1921j15
150. Hms2090p11
151. Hms2092f21
152. Hms2097a18
153. Hms2230l05
154. Hms3370k02
155. Hms3655h05
156. Hms3714a18
157. Pharmakon1600-01501144
158. Component Of Trivalbon (salt/mix)
159. Bcp15413
160. Hy-b0337
161. Tox21_110405
162. Bbl023015
163. Ccg-38972
164. Nsc757860
165. S1962
166. Stk018258
167. Sulfadimethoxine [green Book]
168. Zinc13233295
169. Akos000485038
170. Tox21_110405_1
171. Db06150
172. Ks-5335
173. Sulfadimethoxine [usp Impurity]
174. Sulfadimethoxine For Peak Identification
175. 4-sulfanilamido-2,6-dimethoxypyrimidine
176. Idi1_000088
177. Smp2_000079
178. Sulfadimethoxine [usp Monograph]
179. 2,4-dimethoxy-6-sulfanilamidopyrimidine
180. Ncgc00016375-02
181. Ncgc00016375-03
182. Ncgc00016375-04
183. Ncgc00016375-05
184. Ncgc00016375-06
185. Ncgc00016375-09
186. Ncgc00016375-10
187. Ncgc00024020-03
188. Ncgc00024020-04
189. Ac-10998
190. Sbi-0051656.p002
191. Sulfadimethoxine 100 Microg/ml In Methanol
192. 6-sulfanilamido-2,4-dimethoxy-1,3-diazine
193. Ab00052219
194. B3301
195. Ft-0603324
196. Sulfadimethoxine 1000 Microg/ml In Methanol
197. Sw149624-4
198. 2,4-dimethoxy-6-sulfanilamido-1,3-pyrimidine
199. 22s112
200. D01142
201. H10770
202. Sulfadimethoxine 100 Microg/ml In Acetonitrile
203. Ab00052219-15
204. Ab00052219-17
205. Ab00052219_18
206. Ab00052219_19
207. A804847
208. J-004764
209. Q4921678
210. Sr-01000000227-2
211. Sr-01000000227-4
212. Sulfadimethoxine, Vetranal(tm), Analytical Standard
213. Sulfanilamide, N1-(2,6-dimethoxy-4-pyrimidinyl)-
214. 4-(p-aminobenzenesulfonamido)-2,6-dimethoxypyrimidine
215. Brd-k71125014-001-05-7
216. Brd-k71125014-001-07-3
217. Brd-k71125014-001-17-2
218. N(sup1)-(2,6-dimethoxy-4-pyrimidinyl)sulfanilamide
219. Sulfadimethoxine, Analytical Standard, >=98.5% (tlc)
220. 4-amino-n-[2,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide
221. Sulfadimethoxine, European Pharmacopoeia (ep) Reference Standard
222. Sulfadimethoxine, United States Pharmacopeia (usp) Reference Standard
223. Sulfadimethoxine For Peak Identification, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 310.33 g/mol |
|---|---|
| Molecular Formula | C12H14N4O4S |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 310.07357611 g/mol |
| Monoisotopic Mass | 310.07357611 g/mol |
| Topological Polar Surface Area | 125 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 420 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For use in the treatment of infections.
Sulfadimethoxine has been shown to be effective against streptococci, klebsiella, proteus, shigella, staphylococci, escherichia, and salmonella.
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
J01ED02
S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448
J01ED02
S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01E - Sulfonamides and trimethoprim
J01ED - Long-acting sulfonamides
J01ED01 - Sulfadimethoxine
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Solubilizers
Parenteral
Film Formers & Plasticizers
Emulsifying Agents
Thickeners and Stabilizers
Digital Content
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Sulfadimethoxine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulfadimethoxine, including repackagers and relabelers. The FDA regulates Sulfadimethoxine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulfadimethoxine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sulfadimethoxine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sulfadimethoxine supplier is an individual or a company that provides Sulfadimethoxine active pharmaceutical ingredient (API) or Sulfadimethoxine finished formulations upon request. The Sulfadimethoxine suppliers may include Sulfadimethoxine API manufacturers, exporters, distributors and traders.
click here to find a list of Sulfadimethoxine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sulfadimethoxine DMF (Drug Master File) is a document detailing the whole manufacturing process of Sulfadimethoxine active pharmaceutical ingredient (API) in detail. Different forms of Sulfadimethoxine DMFs exist exist since differing nations have different regulations, such as Sulfadimethoxine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sulfadimethoxine DMF submitted to regulatory agencies in the US is known as a USDMF. Sulfadimethoxine USDMF includes data on Sulfadimethoxine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sulfadimethoxine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sulfadimethoxine suppliers with USDMF on PharmaCompass.
A Sulfadimethoxine CEP of the European Pharmacopoeia monograph is often referred to as a Sulfadimethoxine Certificate of Suitability (COS). The purpose of a Sulfadimethoxine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sulfadimethoxine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sulfadimethoxine to their clients by showing that a Sulfadimethoxine CEP has been issued for it. The manufacturer submits a Sulfadimethoxine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sulfadimethoxine CEP holder for the record. Additionally, the data presented in the Sulfadimethoxine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sulfadimethoxine DMF.
A Sulfadimethoxine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sulfadimethoxine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sulfadimethoxine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sulfadimethoxine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sulfadimethoxine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sulfadimethoxine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sulfadimethoxine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sulfadimethoxine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sulfadimethoxine suppliers with NDC on PharmaCompass.
Sulfadimethoxine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulfadimethoxine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulfadimethoxine GMP manufacturer or Sulfadimethoxine GMP API supplier for your needs.
A Sulfadimethoxine CoA (Certificate of Analysis) is a formal document that attests to Sulfadimethoxine's compliance with Sulfadimethoxine specifications and serves as a tool for batch-level quality control.
Sulfadimethoxine CoA mostly includes findings from lab analyses of a specific batch. For each Sulfadimethoxine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulfadimethoxine may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulfadimethoxine EP), Sulfadimethoxine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulfadimethoxine USP).
LOOKING FOR A SUPPLIER?
